Results 61 to 70 of about 15,811,009 (408)

Positive Feedback Keeps Duration of Mitosis Temporally Insulated from Upstream Cell-Cycle Events [PDF]

open access: yes, 2016
Cell division is characterized by a sequence of events by which a cell gives rise to two daughter cells. Quantitative measurements of cell-cycle dynamics in single cells showed that despite variability in G1-, S-, and G2 phases, duration of mitosis is ...
Araujo, AR   +3 more
core   +1 more source

Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2

open access: yesNucleic Acids Research, 2016
Most RNAs generated by the human genome have no protein-coding ability and are termed non-coding RNAs. Among these include circular RNAs, which include exonic circular RNAs (circRNA), mainly found in the cytoplasm, and intronic RNAs (ciRNA ...
W. Du   +5 more
semanticscholar   +1 more source

Expression of the H2O2 Biosensor roGFP-Tpx1.C169S in Fission and Budding Yeasts and Jurkat Cells to Compare Intracellular H2O2 Levels, Transmembrane Gradients, and Response to Metals

open access: yesAntioxidants, 2023
Intracellular hydrogen peroxide (H2O2) levels can oscillate from low, physiological concentrations, to intermediate, signaling ones, and can participate in toxic reactions when overcoming certain thresholds. Fluorescent protein-based reporters to measure
Laura de Cubas   +5 more
doaj   +1 more source

Reconstructing cell cycle and disease progression using deep learning

open access: yesNature Communications, 2017
We show that deep convolutional neural networks combined with nonlinear dimension reduction enable reconstructing biological processes based on raw image data.
P. Eulenberg   +8 more
semanticscholar   +1 more source

Inactivation of p53 in Human Keratinocytes Leads to Squamous Differentiation and Shedding via Replication Stress and Mitotic Slippage

open access: yesCell Reports, 2014
Tumor suppressor p53 is a major cellular guardian of genome integrity, and its inactivation is the most frequent genetic alteration in cancer, rising up to 80% in squamous cell carcinoma (SCC).
Ana Freije   +9 more
doaj   +1 more source

A new framework for identifying combinatorial regulation of transcription factors: a case study of the yeast cell cycle [PDF]

open access: yesJournal of Biomedical Informatics Volume 40, Issue 6, December 2007, Pages 707-725. Intelligent Data Analysis in Biomedicine, 2010
By integrating heterogeneous functional genomic datasets, we have developed a new framework for detecting combinatorial control of gene expression, which includes estimating transcription factor activities using a singular value decomposition method and reducing high-dimensional input gene space by considering genomic properties of gene clusters.
arxiv   +1 more source

Cell Cycle Development [PDF]

open access: yesDevelopmental Cell, 2004
The Keystone Symposium on the Cell Cycle and Development brought together biologists with an interest in how cell cycle control is integrated into the ontogenetic program of multicellular organisms, and showcased research using a wide variety of systems from both animals and plants.
openaire   +2 more sources

DYRK1A and the Cell Cycle [PDF]

open access: yes, 2020
The ability to halt the cell cycle is critical for cells to maintain tissue and organ size, to suppress tumors and abnormal growth, and exists as a helpful mechanism to pause the cell cycle for DNA repair.
Byers, Holly   +1 more
core   +1 more source

Leveraging current insights on IL‐10‐producing dendritic cells for developing effective immunotherapeutic approaches

open access: yesFEBS Letters, EarlyView.
In vivo IL‐10 produced by tissue‐resident tolDC is involved in maintaining/inducing tolerance. Depending on the agent used for ex vivo tolDC generation, cells acquire common features but prime T cells towards anergy, FOXP3+ Tregs, or Tr1 cells according to the levels of IL‐10 produced. Ex vivo‐induced tolDC were administered to patients to re‐establish/
Konstantina Morali   +3 more
wiley   +1 more source

Lights and Shadows on the Cancer Multi-Target Inhibitor Rigosertib (ON-01910.Na)

open access: yesPharmaceutics, 2023
Rigosertib (ON-01910.Na) is a small-molecule member of the novel synthetic benzyl-styryl-sulfonate family. It is currently in phase III clinical trials for several myelodysplastic syndromes and leukemias and is therefore close to clinical translation ...
Ana Monfort-Vengut, Guillermo de Cárcer
doaj   +1 more source

Home - About - Disclaimer - Privacy